Drugs / BERSIPOROCIN
BERSIPOROCIN
also known as
DWN12088 · BERSIPOROCIN HYDROCHLORIDE · Bersiporocina · Bersiporocine · DWN-12088 HYDROCHLORIDE
Trials 4 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 13 trials | ||||||
| Phase 1 | NCT04888715 | Jul → Aug 2021 | idiopathic pulmonary fibrosis | Daewoong Pharmaceutical Co. LTD. | Completed | No outcome recorded |
| Phase 1 | NCT04888728 | Jun → Jul 2021 | idiopathic pulmonary fibrosis | Daewoong Pharmaceutical Co. LTD. | Completed | No outcome recorded |
| Phase 1 | NCT04767815 | Mar → May 2021 | idiopathic pulmonary fibrosis | Daewoong Pharmaceutical Co. LTD. | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT05389215 | Jul 2022 → Oct 2026 expected | idiopathic pulmonary fibrosis | Daewoong Pharmaceutical Co. LTD. | Active not recruiting | No outcome recorded |
Evidence & citations 9 cited values
Every value below carries the sentence it was read from. 5 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BERSIPOROCIN | ChEMBL registry synonym — accepted as the source's own label CHEMBL4802138 ↗ |
| Known as | BERSIPOROCIN HYDROCHLORIDE | ChEMBL registry synonym — accepted as the source's own label CHEMBL4802138 ↗ |
| Known as | Bersiporocina | ChEMBL registry synonym — accepted as the source's own label CHEMBL4802138 ↗ |
| Known as | Bersiporocine | ChEMBL registry synonym — accepted as the source's own label CHEMBL4802138 ↗ |
| Known as | DWN-12088 HYDROCHLORIDE | ChEMBL registry synonym — accepted as the source's own label CHEMBL4802138 ↗ |
| Known as | DWN12088 | “Fasting + DWN12088 200 mg” NCT04767815 ↗ |
| Action | Inhibit | “Prolyl-tRNA synthetase (PRS) inhibitor” NCT04888715 ↗ |
| Modality | Small molecule | — CHEMBL4802138 ↗ |
| Route | Oral | “single oral dose of DWN12088” NCT04767815 ↗ |